BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11689915)

  • 1. Give and take the lead.
    Fitzpatrick SM
    Nature; 2001 Nov; 414(6859):15. PubMed ID: 11689915
    [No Abstract]   [Full Text] [Related]  

  • 2. US stem cell policy comes under fire.
    Fletcher L
    Nat Biotechnol; 2001 Oct; 19(10):893-4. PubMed ID: 11581638
    [No Abstract]   [Full Text] [Related]  

  • 3. Embryonic stem cell research controversy: focus on the private sector and international sphere.
    Kim S
    Hastings Womens Law J; 2003; 14(1):89-108. PubMed ID: 16032810
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem-cell lines.
    Wall St J (East Ed); 2005 May; ():A12. PubMed ID: 15966127
    [No Abstract]   [Full Text] [Related]  

  • 5. Fundraising 101: why seek private funding?
    Duyck GP
    J Public Health Manag Pract; 2008; 14(2):199-201. PubMed ID: 18287928
    [No Abstract]   [Full Text] [Related]  

  • 6. The politics of bioethics.
    Cohen E; Kristol W
    Hum Life Rev; 2004; 30(2):7-15. PubMed ID: 15540375
    [No Abstract]   [Full Text] [Related]  

  • 7. Silicon philanthropists follow a great tradition.
    Fitzpatrick SM
    Nature; 2001 Apr; 410(6830):739. PubMed ID: 11298406
    [No Abstract]   [Full Text] [Related]  

  • 8. Who said murder?
    New Sci; 2006 Jul 29-Aug 4; 191(2562):3. PubMed ID: 17115485
    [No Abstract]   [Full Text] [Related]  

  • 9. Innovation in biomedicine: can stem cell research lead the way to affordability?
    Goozner M
    PLoS Med; 2006 Feb; 3(5):e126. PubMed ID: 16492088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. California Stem Cell Research and Cures Act: what to expect from stem cell research?
    Panetta J; Wetherell J; Mehok M
    J Biolaw Bus; 2005; 8(4):3-12. PubMed ID: 16619447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The battle over stem cells.
    Randerson J
    New Sci; 2004 Oct 9-15; 184(2468):23. PubMed ID: 15543680
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloning for therapeutic purposes: ethical and policy considerations.
    Hanson MJ
    Univ Toledo Law Rev; 2001; 32(3):355-65-. PubMed ID: 12627582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The appropriate limits of science in the formation of public policy.
    Condic ML; Condic SB
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):157-79. PubMed ID: 14986651
    [No Abstract]   [Full Text] [Related]  

  • 14. The business of human embryonic stem cell research and an international analysis of relevant laws.
    De Trizio E; Brennan CS
    J Biolaw Bus; 2004; 7(4):14-22. PubMed ID: 15675095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement.
    Biotechnology Industry Organization
    J Biolaw Bus; 1999; 3(1):40-4. PubMed ID: 11933970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating scientific research: intellectual property rights and the norms of science.
    Rai AK
    Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
    [No Abstract]   [Full Text] [Related]  

  • 17. The intersection of law and medicine: the case for providing federal funding for embryonic stem cell research.
    Newhart AB
    Villanova Law Rev; 2004; 49(2):329-61. PubMed ID: 16485376
    [No Abstract]   [Full Text] [Related]  

  • 18. How the US government can fund your company.
    Basu P
    Nat Biotechnol; 2004 Apr; 22(4):482-6. PubMed ID: 15085814
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting stem-cell research in perspective.
    George F
    Origins; 2001 Aug; 31(12):215. PubMed ID: 11838495
    [No Abstract]   [Full Text] [Related]  

  • 20. Federal funding of human embryonic stem cell research: an institutional examination.
    Fujikawa R
    South Calif Law Rev; 2005 May; 78(4):1075-124. PubMed ID: 17340756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.